Val T. Hoyle sold BioNTech SE (NASDAQ: BNTX)
Val T. Hoyle (D-OR), a U.S. Representative, has disclosed 1 trade in BioNTech SE (BNTX) since 2025, a single sale, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Val T. Hoyle sold $1,001 - $15,000 of BioNTech SE (NASDAQ: BNTX) on August 7, 2025. Since that trade, BNTX is down -16.52% against the S&P 500 up +16.35%, an outperformance of -32.88%.
Data updated
Val T. Hoyle's BNTX trades vs the price
BNTX is down -16.52% since Val T. Hoyle sold on August 7, 2025, versus +16.35% for the S&P 500.
Performance since this trade
All Val T. Hoyle BNTX trades
Val T. Hoyle & BNTX trading FAQ
Is it legal for Val T. Hoyle to trade BioNTech SE (BNTX) stock?
Yes. Members of Congress are allowed to trade individual stocks, including BioNTech SE (BNTX), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Val T. Hoyle sell BNTX?
Val T. Hoyle disclosed a sale of $1,001 - $15,000 of BioNTech SE (BNTX) on August 7, 2025, according to public STOCK Act filings.
How has BNTX performed since Val T. Hoyle's trade?
Since Val T. Hoyle sold BNTX on August 7, 2025, the stock is down -16.52%, versus +16.35% for the S&P 500 over the same period, an outperformance of -32.88%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional BNTX trades?
Quantellect tracks every disclosed congressional trade in BioNTech SE (BNTX) on the BioNTech SE congressional trading page, which aggregates filings across all members of Congress.
Val T. Hoyle's BNTX tradesAll congressional filings for BioNTech SEVal T. Hoyle's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.